Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 273 followers
Latest posts
Last updated about 12 hours ago
Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 38, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of...
Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Date of authorisation: 26/07/2018, Revision: 16, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Alofisel, darvadstrocel, Date of authorisation: 23/03/2018, Revision: 12, Status: Withdrawn
about 13 hours ago
Human medicines European public assessment report (EPAR): Alofisel, darvadstrocel, Date of authorisation...
List of eligible industry stakeholder organisations
about 14 hours ago
List of eligible industry stakeholder organisations
Product Management Service (PMS) information day 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 21 May 2025, 09:00 (CEST) to 21 May 2025, 17:30 (CEST)
about 14 hours ago
Product Management Service (PMS) information day 2025, Online, European Medicines Agency, Amsterdam...
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 17, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation: 01/12/2023, Revision: 2, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Zilbrysq, Zilucoplan, Date of authorisation...
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation: 27/07/2020, Revision: 2, Status: Authorised
about 19 hours ago
Human medicines European public assessment report (EPAR): Xenleta, lefamulin, Date of authorisation...